Delivery Order SPE2DB22D1041-SPE2DB25FTXX4

Award Date 10/15/24
Potential Completion Date 10/16/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $14,410.55 firm fixed price contract is for the supply of Candesartan Cilexetil 16 MG tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and Amerisourcebergen, which provides a wide range of pharmaceutical and medical supplies to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a firm fixed price, a ceiling value of $4,120.47, and a period of performance through May 16, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $3,734.76, is for the supply of Candesartan Cilexetil 8 mg tablets. The contract has an ultimate completion date of April 23, 2025 and is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corporation holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides Candesartan Cilexetil 32 mg tablets to the DLA in support of military and veterans' healthcare programs. The delivery order has a ceiling value of $5,329.99 and was awarded on September 23, 2021, with a completion date of September 24, 2021. The contract is a firm...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of Candesartan 16 mg tablets. The contract has a ceiling value of $2,304.16 and a period of performance through September 27, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division for the supply of Candesartan Cilexetil 16 mg tablets. The delivery order has a ceiling value of $30,418.80 and runs through August 27, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with DLA Troop Support Medical...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,127.39 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 4 mg tablets in 90-count packages. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of 4,567,796,117 units of Candesartan Cilexetil 32 mg tablets in 90-count packages. The contract has a ceiling value of $8,522.65 and is a Firm Fixed Price Delivery Order with an ultimate completion date of April 4, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,832.28, is for the provision of Candesartan Cilexetil 32 mg tablets. The contract is a firm fixed-price delivery order with a period of performance through November 6, 2024. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Candesartan Cilexetil 16 mg tablets, a pharmaceutical product used in the treatment of hypertension and heart failure. The contract has a ceiling value of $11,747.16 and a period of performance through May 13, 2025. This contract is not designated as a set-aside and was awarded on...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB25FTXX4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 32 mg Candesartan Cilexetil tablets, a pharmaceutical product, and has a ceiling value of $14,864.29. The contract is a firm-fixed price delivery order with an ultimate completion date of October 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and veterans' healthcare programs. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999 and $750,000 respectively, for providing a wide range of essential medical commodities to support federal healthcare needs. This contract award is not associated with any set-aside designation.

Generated 1/14/25, 9:24 AM